The store will not work correctly when cookies are disabled.
(S)-2-(2-fluorophenyl)-3-phenyl-2,3-dihydroquinazolin-4(1H)-one
ID: ALA4063020
PubChem CID: 712061
Max Phase: Preclinical
Molecular Formula: C20H15FN2O
Molecular Weight: 318.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2ccccc2N[C@H](c2ccccc2F)N1c1ccccc1
Standard InChI: InChI=1S/C20H15FN2O/c21-17-12-6-4-10-15(17)19-22-18-13-7-5-11-16(18)20(24)23(19)14-8-2-1-3-9-14/h1-13,19,22H/t19-/m0/s1
Standard InChI Key: UMMDFHVNOCVOCD-IBGZPJMESA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
14.2004 -3.4999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1992 -4.3194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9073 -4.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9055 -3.0910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6141 -3.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6129 -4.3214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3230 -4.7328 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0389 -4.3235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0400 -3.4983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3254 -3.0824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3254 -2.2652 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.7487 -3.0914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4540 -3.5060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1623 -3.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1647 -2.2818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4530 -1.8716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7477 -2.2802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7454 -4.7341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7379 -5.5522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4436 -5.9627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1535 -5.5560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1531 -4.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4468 -4.3278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0277 -5.9564 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
8 18 1 1
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
19 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 318.35 | Molecular Weight (Monoisotopic): 318.1168 | AlogP: 4.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 32.34 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.87 | CX Basic pKa: ┄ | CX LogP: 5.07 | CX LogD: 5.07 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -1.03 |
References
1. Jiang Y, Zhuang C, Chen L, Lu J, Dong G, Miao Z, Zhang W, Li J, Sheng C.. (2017) Structural Biology-Inspired Discovery of Novel KRAS-PDEδ Inhibitors., 60 (22): [PMID:28929751] [10.1021/acs.jmedchem.7b01243] |